Evaluation of conversion rate after transarterial chemoemobolization using for unresectable hepatocellular carcinoma
Phase 2
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000014252
- Lead Sponsor
- Multicenter Clinical Study Group of Osaka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patologically diagnosed as combined hepatocellular and cholangiocellular carcinoma 2) Extrahepatic metastasis 3) Vascular involvement Vp3 or more 4) Hepatic encephalopathy 5) Active infection except for HBV and HCV 6) Severee complications 7) acitve double cancer 8) Pregnant, possibility of pregnancy, or feeding a baby Pregnancy 9) Medication that may affect to the absorption of drug or pharmacokinetics 10) Other factors that a responsible doctor judged to be unsuitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Conversion rate for salvage surgery
- Secondary Outcome Measures
Name Time Method Response rate for TACE, Time to progression (TTP), Overall survival (OS), disease-free survival time after salvage hepatectomy, completion rate, safty & adverse event